Shield Therapeutics plc
SHIEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $31,259 | $47,439 | $15,693 | $87,062 |
| - Cash | $6,524 | $13,948 | $2,821 | $12,117 |
| + Debt | $26,370 | $20,245 | $6,097 | $156 |
| Enterprise Value | $51,105 | $53,736 | $18,969 | $75,101 |
| Revenue | $32,180 | $13,085 | $4,549 | $1,519 |
| % Growth | 145.9% | 187.7% | 199.5% | – |
| Gross Profit | $14,930 | $4,027 | $2,033 | $539 |
| % Margin | 46.4% | 30.8% | 44.7% | 35.5% |
| EBITDA | -$21,258 | -$30,288 | -$24,547 | -$18,753 |
| % Margin | -66.1% | -231.5% | -539.6% | -1,234.6% |
| Net Income | -$27,182 | -$33,293 | -$49,789 | -$19,678 |
| % Margin | -84.5% | -254.4% | -1,094.5% | -1,295.5% |
| EPS Diluted | -0.03 | -0.046 | -0.21 | -0.092 |
| % Growth | 34.9% | 78% | -128.5% | – |
| Operating Cash Flow | -$6,770 | -$29,123 | -$18,247 | -$16,738 |
| Capital Expenditures | -$2,421 | -$2,948 | -$1,895 | -$2,064 |
| Free Cash Flow | -$9,191 | -$40,074 | -$20,142 | -$18,802 |